Molecular Reagent HemeScreen® CEBPA For Research Use Only For HRM-enabled RT-PCR Machine / AML Panel 100 Tests

Features

• Precipio’s HemeScreen® offerings are Research Use Only (RUO) assays that screen for clinically actionable somatic mutations in targets of interest related to myeloproliferative disorders and haematological cancers
• The reagents are designed to be used in a clinical diagnostic laboratory by suitably trained personnel testing DNA extracted from whole blood or bone marrow using a PCR-based method and High Resolution Melt (HRM) Analysis
• CEBPA (CCAAT/enhancer binding protein ɑ) mutations can be seen in 15% - 19% of AML samples
• CEBPA mutations have a favorable prognosis, when no FLT3 mutation is present; regardless of cytogenetic abnormalities
• Free-Flow Reagent
• Each HemeScreen® reagent sets contains enough reactions for 100 samples in duplicate and includes enough Mutant control for 5 reactions
• Reagent sets should be stored in the dark between -18 °C and -25 °C in a constant temperature freezer until use
• Machine required HRM-enabled RT-PCR (example/ ThermoFisher Quantstudio 3 or higher)

More Information

• SDS